Literature DB >> 8641692

Hereditary ceruloplasmin deficiency with hemosiderosis.

N Okamoto1, S Wada, T Oga, Y Kawabata, Y Baba, D Habu, Z Takeda, Y Wada.   

Abstract

Hereditary ceruloplasmin deficiency with hemosiderosis (aceruloplasminemia) is a new disease characterized by systemic hemosiderosis, diabetes mellitus, neurological abnormalities and pigment degeneration of the retina. Loss of the ferroxidase activity of ceruloplasmin results in systemic iron deposition and tissue damage. Neuroimaging studies reveal iron deposition in basal ganglia and in the red and dentate nuclei. Cerebellar ataxia, extrapyramidal signs and dementia develop after middle age. We report a patient with undetectable serum ceruloplasmin levels and the above clinical manifestations. Sequence analysis of the cDNA of ceruloplasmin from this patient revealed an insertion of adenine in exon 3; this produced a premature stop codon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641692     DOI: 10.1007/bf02346185

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  Ceruloplasmin. A scavenger of superoxide anion radicals.

Authors:  I M Goldstein; H B Kaplan; H S Edelson; G Weissmann
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

2.  A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.

Authors:  K Yoshida; K Furihata; S Takeda; A Nakamura; K Yamamoto; H Morita; S Hiyamuta; S Ikeda; N Shimizu; N Yanagisawa
Journal:  Nat Genet       Date:  1995-03       Impact factor: 38.330

3.  Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein.

Authors:  J Chelly; Z Tümer; T Tønnesen; A Petterson; Y Ishikawa-Brush; N Tommerup; N Horn; A P Monaco
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

4.  The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.

Authors:  S Osaki; D A Johnson; E Frieden
Journal:  J Biol Chem       Date:  1966-06-25       Impact factor: 5.157

5.  Mapping, cloning and genetic characterization of the region containing the Wilson disease gene.

Authors:  K Petrukhin; S G Fischer; M Pirastu; R E Tanzi; I Chernov; M Devoto; L M Brzustowicz; E Cayanis; E Vitale; J J Russo
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

6.  The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene.

Authors:  R E Tanzi; K Petrukhin; I Chernov; J L Pellequer; W Wasco; B Ross; D M Romano; E Parano; L Pavone; L M Brzustowicz
Journal:  Nat Genet       Date:  1993-12       Impact factor: 38.330

7.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Authors:  Z L Harris; Y Takahashi; H Miyajima; M Serizawa; R T MacGillivray; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase.

Authors:  C Vulpe; B Levinson; S Whitney; S Packman; J Gitschier
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

9.  Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus.

Authors:  J I Logan; K B Harveyson; G B Wisdom; A E Hughes; G P Archbold
Journal:  QJM       Date:  1994-11

10.  Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration.

Authors:  H Miyajima; Y Nishimura; K Mizoguchi; M Sakamoto; T Shimizu; N Honda
Journal:  Neurology       Date:  1987-05       Impact factor: 9.910

View more
  12 in total

1.  Aceruloplasminemia: a case report.

Authors:  Domenico Di Raimondo; Antonio Pinto; Antonino Tuttolomondo; Paola Fernandez; Clara Camaschella; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2008-04-12       Impact factor: 3.397

2.  Chloride Control of the Mechanism of Human Serum Ceruloplasmin (Cp) Catalysis.

Authors:  Shiliang Tian; Stephen M Jones; Anex Jose; Edward I Solomon
Journal:  J Am Chem Soc       Date:  2019-06-27       Impact factor: 15.419

3.  Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells.

Authors:  Huijun Chen; Zouhair K Attieh; Basharut A Syed; Yien-Ming Kuo; Valerie Stevens; Brie K Fuqua; Henriette S Andersen; Claire E Naylor; Robert W Evans; Lorraine Gambling; Ruth Danzeisen; Mhenia Bacouri-Haidar; Julnar Usta; Chris D Vulpe; Harry J McArdle
Journal:  J Nutr       Date:  2010-08-04       Impact factor: 4.798

4.  MR imaging of cerebral cortical involvement in aceruloplasminemia.

Authors:  Marina Grisoli; Alberto Piperno; Luisa Chiapparini; Raffaella Mariani; Mario Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

5.  Iron in neurodegenerative disorders.

Authors:  D. Berg; G. Becker; P. Riederer; O. Riess
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

6.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation.

Authors:  A McNeill; D Birchall; S J Hayflick; A Gregory; J F Schenk; E A Zimmerman; H Shang; H Miyajima; P F Chinnery
Journal:  Neurology       Date:  2008-04-29       Impact factor: 9.910

7.  Iron, copper, and zinc distribution of the cerebellum.

Authors:  Bogdan F Gh Popescu; Christopher A Robinson; Alex Rajput; Ali H Rajput; Sheri L Harder; Helen Nichol
Journal:  Cerebellum       Date:  2009-01-13       Impact factor: 3.847

8.  Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone.

Authors:  Liangliang Zhao; Majda Hadziahmetovic; Chenguang Wang; Xueying Xu; Ying Song; H A Jinnah; Jolanta Wodzinska; Jared Iacovelli; Natalie Wolkow; Predrag Krajacic; Alyssa Cwanger Weissberger; John Connelly; Michael Spino; Michael K Lee; James Connor; Benoit Giasson; Z Leah Harris; Joshua L Dunaief
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

9.  Functional studies of hephaestin in yeast: evidence for multicopper oxidase activity in the endocytic pathway.

Authors:  Liangtao Li; Chris D Vulpe; Jerry Kaplan
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

10.  Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.

Authors:  Daniela Braconi; Claretta Bianchini; Giulia Bernardini; Marcella Laschi; Lia Millucci; Adriano Spreafico; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2011-08-27       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.